Kim-Arthur Baffert
Centre Léon Bérard(FR)Centre Hospitalier Universitaire de Limoges(FR)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cancer survivorship and care, Head and Neck Cancer Studies, Cancer Treatment and Pharmacology, Oral health in cancer treatment
Most-Cited Works
- → Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients(2022)63 cited
- → Quality of Life of Patients With Cancer During the COVID-19 Pandemic(2021)46 cited
- → Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitors(2022)19 cited
- → Renin-Angiotensin-System Inhibitors for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: OncoToxSRA, a Preliminary Cohort Study(2022)12 cited
- → Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial(2022)12 cited
- → THERANOVA-LIM: Improving knowledge of oral therapies for patients and healthcare professionals(2024)
- → THERANOVA-LIM: Optimizing the city hospital link to support patients on oral anticancer drugs(2024)
- → Administration des anti-HER2 et satisfaction des patients avec un cancer du sein(2024)
- → THERANOVA-LIM : améliorer l’accès à l’information sur les traitements oraux pour les patients et les pharmaciens(2025)
- → Abstract 735: Immunologically active phenotype by gene expression profiling predicts clinical benefit from PD-1/PD-L1 inhibitors in a pancancer cohort(2025)